Xylanaest Purum

Xylanaest Purum contains lidocaine hydrochloride, a local anaesthetic used for numbing specific areas during medical procedures. It is administered via infiltration and is commonly used in both minor and major surgical interventions. This product is manufactured by Gebro Pharma GmbH and is available in the EU market.

Lidocaine hydrochloride, the active ingredient in Xylanaest Purum, is primarily used for local anaesthesia to numb specific areas of the body. It is commonly employed in dental procedures, minor surgeries, and diagnostic interventions where temporary loss of sensation is required. This medication is suitable for infiltration anaesthesia, providing targeted pain relief during medical treatments.

Xylanaest Purum works by temporarily blocking nerve signals in the area where it is administered, resulting in a loss of sensation. Users may experience numbness in the targeted region, which helps reduce discomfort during procedures. The effects are temporary and wear off as the medication is metabolized by the body.

Xylanaest Purum should be handled with care and administered by a healthcare professional. It is important to inform the provider of any allergies, especially to anaesthetics or other medications. Patients should avoid driving or operating machinery immediately after use, as the numbing effect may impair coordination.

Lidocaine hydrochloride may interact with other medications, particularly those affecting heart rhythm or blood pressure. Caution is advised when used alongside drugs that prolong the QT interval or have sedative effects. Alcohol and certain herbal supplements may also influence the effectiveness or side effects of this anaesthetic.